Neoplasm Recurrence, LocalRecurrenceNeoplasm MetastasisBreast NeoplasmsPrognosisChemotherapy, AdjuvantNeoplasm StagingDisease-Free SurvivalTreatment OutcomeRetrospective StudiesCombined Modality TherapyLymphatic MetastasisRadiotherapy, AdjuvantSurvival RateSurvival AnalysisFollow-Up StudiesReceptors, EstrogenTamoxifenRectal NeoplasmsSarcomaReceptors, ProgesteroneAntineoplastic Agents, HormonalTumor Markers, BiologicalAntineoplastic Combined Chemotherapy ProtocolsReceptor, erbB-2Mastectomy, SegmentalKaplan-Meier EstimateNeoplasm InvasivenessMastectomyAdenocarcinomaLymph Node ExcisionFluorouracilProportional Hazards ModelsCarcinoma, Ductal, BreastBone NeoplasmsRisk FactorsProspective StudiesMultivariate AnalysisLymph NodesNeoadjuvant TherapyTime FactorsPredictive Value of TestsRandomized Controlled Trials as TopicRisk AssessmentImmunohistochemistryMelanomaProstatic NeoplasmsLiver NeoplasmsPostmenopauseLung NeoplasmsDisease ProgressionTomography, X-Ray ComputedSpinal NeoplasmsPancreatic NeoplasmsOsteosarcomaUveal NeoplasmsAntineoplastic AgentsNeoplastic Cells, CirculatingSkin NeoplasmsColorectal NeoplasmsFemoral NeoplasmsKidney NeoplasmsSoft Tissue NeoplasmsProstate-Specific AntigenCarcinoma, Renal CellPalliative CarePelvic NeoplasmsPositron-Emission TomographyUrinary Bladder NeoplasmsAbdominal NeoplasmsCell Line, TumorSarcoma, EwingRadiopharmaceuticalsProstatectomyCarcinoma, Squamous CellCarcinomaThyroid NeoplasmsChoroid NeoplasmsFluorodeoxyglucose F18Drug Administration ScheduleSensitivity and SpecificityCisplatinBrain NeoplasmsDoxorubicinGene Expression Regulation, NeoplasticNeoplasmsCarcinoma, HepatocellularLeucovorinDeoxycytidineCarcinoma, Transitional CellThoracic NeoplasmsBone Marrow NeoplasmsParagangliomaEye EnucleationNeuroendocrine TumorsMultimodal ImagingHepatectomyHead and Neck NeoplasmsSentinel Lymph Node BiopsyBiopsy, Needle